参考文献/References:
[1] 吕遐,扶琼.原发性骨质疏松症的研究进展与最新指南解读[J].临床内科杂志,2020,37(5):319-322.
[2] 吴博.骨质疏松症病因的研究进展[J].医学食疗与健康,2020,18(7):198.
[3] DU J K,YANG J C,HE Z H,et al.Osteoblast and osteoclast activity affect bone remodeling upon regulation by mechanical loading-induced leukemia inhibitory factor expression in osteocytes[J].Front Mol Biosci,2020
[2020-09-10].https://www.frontiersin.org/articles/10.3389/fmolb.2020.585056/full.
[4] TAKAYANAGI H.Osteoimmunology-bidirectional dialogue and inevitable union of the fields of bone and immunity[J].Proc Jpn Acad Ser B Phys Biol Sci,2020,96(4):159-169.
[5] WALSH M C,TAKEGAHARA N,KIM H,et al.Updating osteoimmunology:regulation of bone cells by innate and adaptive immunity[J].Nat Rev Rheumatol,2018,14(3):146-156.
[6] VIGNESH P,RAWAT A,SHARMA M,et al.Complement in autoimmune diseases[J].Clin Chim Acta,2017,465:123-130.
[7] SATO T,ABE E,JIN C H,et al.The biological roles of the third component of complement in osteoclast formation[J].Endocrinology,1993,133(1):397-404.
[8] RICKLIN D,HAJISHENGALLIS G,YANG K,et al.Complement:a key system for immune surveillance and homeostasis[J].Nat Immunol,2010,11(9):785-797.
[9] MULLINS R F,RUSSELL S R,ANDERSON D H,et al.Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis,elastosis,amyloidosis,and dense deposit disease[J].FASEB J,2000,14(7):835-846.
[10] WALPORT M J.Complement.First of two parts[J].N Engl J Med,2001,344(14):1058-1066.
[11] AL BARI A A,AL MAMUN A.Current advances in regulation of bone homeostasis[J].FASEB Bioadv,2020,2(11):668-679.
[12] KOVACS B,VAJDA E,NAGY E E.Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis[J].Int J Mol Sci,2019,20(18):4653.
[13] SATO T,ABE E,JIN C H,et al.The biological roles of the third component of complement in osteoclast formation[J].Endocrinology,1993,133(1):397-404.
[14] IGNATIUS A,SCHOENGRAF P,KREJA L,et al.Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β[J].J Cell Biochem,2011,112(9):2594-2605.
[15] MACKAY D L,KEAN T J,BERNARDI K G,et al.Reduced bone loss in a murine model of postmenopausal osteoporosis lacking complement component 3[J].J Orthop Res,2018,36(1):118-128.
[16] LUBBERS R,VAN SCHAARENBURG R A,KWEKKEBOOM J C,et al.Complement component C1q is produced by isolated articular chondrocytes[J].Osteoarthritis Cartilage,2020,28(5):675-684.
[17] KUO S J,WANG F S,SHEEN J M,et al.Complement component C3:serologic signature for osteogenesis imperfecta.Analysis of a comparative proteomic study[J].J Formos Med Assoc,2015,114(10):943-949.
[18] MATSUOKA K,PARK K A,ITO M,et al.Osteoclast-derived complement component 3a stimulates osteoblast differentiation[J].J Bone Miner Res,2014,29(7):1522-1530.
[19] SUZUKI M,HASHIZUME M,YOSHIDA H,et al.Intercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor kappaB ligand[J].Clin Exp Immunol,2011,163(1):88-95.
[20] TU Z D,BU H,DENNIS J E,et al.Efficient osteoclast differentiation requires local complement activation[J].Blood,2010,116(22):4456-4463.
[21] FATTAHI F,FRYDRYCH L M,BIAN G,et al.Role of complement C5a and histones in septic cardiomyopathy[J].Mol Immunol,2018,102:32-41.
[22] GENDRON S,BOISVERT M,CHETOUI N,et al.α1β1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function[J].Immunology,2008,125(3):359-369.
[23] WEITZMANN M N,OFOTOKUN I.Physiological and pathophysiological bone turnover-role of the immune sys-tem[J].Nat Rev Endocrinol,2016,12(9):518-532.
[24] MASUZAW T,MIYAURA C,ONOE Y,et al.Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow[J].J Clin Invest,1994,94(3):1090-1097.
[25] PAN M X,HONG W,YAO Y,et al.Activated B lymphocyte inhibited the osteoblastogenesis of bone mesenchymal stem cells by Notch signaling[J].Stem Cells Int,2019
[2020-09-10].https://www.hindawi.com/journals/sci/2019/8150123/.
[26] ZHANG W J,DANG K,HUAI Y,et al.Osteoimmunology:the regulatory roles of T lymphocytes in osteoporosis[J].Front Endocrinol(Lausanne),2020,11:465.
[27] ZHAO J J,WU Z F,YU Y H,et al.Effects of interleukin-7/interleukin-7 receptor on RANKL-mediated osteoclast differentiation and ovariectomy-induced bone loss by regulating c-Fos/c-Jun pathway[J].J Cell Physiol,2018,233(9):7182-7194.
[28] GENDRON S,BOISVERT M,CHETOUI N,et al.Alpha1 beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function[J].Immunology,2008,125(3):359-369.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(02):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(02):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(02):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(02):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(02):16.